Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Cortes, Javier, MD, O'Shaughnessy, Joyce, MD, Loesch, David, MD, Blum, Joanne L, MD, Vahdat, Linda T, MD, Petrakova, Katarina, MD, Chollet, Philippe, MD, Manikas, Alexey, MD, Diéras, Veronique, MD, Delozier, Thierry, MD, Vladimirov, Vladimir, MD, Cardoso, Fatima, MD, Koh, Han, MD, Bougnoux, Philippe, MD, Dutcus, Corina E, MD, Seegobin, Seth, MSc, Mir, Denis, MSc, Meneses, Nicole, MSHS, Wanders, Jantien, MD, Twelves, Chris, Prof
Published in The Lancet (British edition) (12.03.2011)
Published in The Lancet (British edition) (12.03.2011)
Get full text
Journal Article
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Cortes, Javier, Vahdat, Linda, Blum, Joanne L, Twelves, Chris, Campone, Mario, Roché, Henri, Bachelot, Thomas, Awada, Ahmad, Paridaens, Robert, Goncalves, Anthony, Shuster, Dale E, Wanders, Jantien, Fang, Fang, Gurnani, Renuka, Richmond, Elaine, Cole, Patricia E, Ashworth, Simon, Allison, Mary Ann
Published in Journal of clinical oncology (01.09.2010)
Published in Journal of clinical oncology (01.09.2010)
Get full text
Journal Article
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
Schöffski, Patrick, Prof, Ray-Coquard, Isabelle Laure, MD, Cioffi, Angela, MD, Bui, Nguyen Bin, MD, Bauer, Sebastian, MD, Hartmann, Joerg Thomas, Prof, Krarup-Hansen, Anders, MD, Grünwald, Viktor, MD, Sciot, Raf, Prof, Dumez, Herlinde, Prof, Blay, Jean-Yves, Prof, Le Cesne, Axel, MD, Wanders, Jantien, MD, Hayward, Carolyn, MD, Marreaud, Sandrine, MD, Ouali, Monia, MSc, Hohenberger, Peter, Prof
Published in The lancet oncology (01.10.2011)
Published in The lancet oncology (01.10.2011)
Get full text
Journal Article
Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer
KAUFMANN, Andreas M, STERN, Peter L, KROON, Karlijn, HICKLING, Julian, BOSWELL, Christopher M, STACEY, Simon N, KITCHENER, Henry C, GILLARD, Jennifer, WANDERS, Jantien, ROBERTS, John St. C, ZWIERZINA, Heinz, RANKIN, Elaine M, SOMMER, Harald, NUESSLER, Volkmar, SCHNEIDER, Achim, ADAMS, Malcom, ONON, Toli S, BAUKNECHT, Thomas, WAGNER, Uwe
Published in Clinical cancer research (01.12.2002)
Get full text
Published in Clinical cancer research (01.12.2002)
Journal Article
Phase I and Pharmacokinetic Study of the Dolastatin 10 Analogue TZT-1027, Given on Days 1 and 8 of a 3-Week Cycle in Patients with Advanced Solid Tumors
de Jonge, Maja J A, van der Gaast, Ate, Planting, André S T, van Doorn, Leny, Lems, Aletta, Boot, Inge, Wanders, Jantien, Satomi, Masahiko, Verweij, Jaap
Published in Clinical cancer research (15.05.2005)
Published in Clinical cancer research (15.05.2005)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
SOEPENBERG, Otto, DE JONGE, Maja J. A, SPARREBOOM, Alex, DE BRUIN, Peter, ESKENS, Ferry A. L. M, DE HEUS, Gerda, WANDERS, Jantien, CHEVERTON, Peter, DUCHARME, Murray P, VERWEIJ, Jaap
Published in Clinical cancer research (15.01.2005)
Published in Clinical cancer research (15.01.2005)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of E7070, a Chloroindolyl-Sulfonamide Anticancer Agent, Administered on a Weekly Schedule to Patients with Solid Tumors
DITTRICH, Christian, DUMEZ, Herlinde, CALVERT, Hilary, HANAUSKE, Axel, FABER, Marije, WANDERS, Jantien, YULE, Murray, RAVIC, Miroslav, FUMOLEAU, Pierre
Published in Clinical cancer research (01.11.2003)
Get full text
Published in Clinical cancer research (01.11.2003)
Journal Article
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam
van Kesteren, Charlotte, Zandvliet, Anthe S, Karlsson, Mats O, Mathôt, Ron A A, Punt, Cornelis J A, Armand, Jean-Pierre, Raymond, Eric, Huitema, Alwin D R, Dittrich, Christian, Dumez, Herlinde, Roché, Henri H, Droz, Jean-Pierre, Ravic, Miroslav, Yule, S Murray, Wanders, Jantien, Beijnen, Jos H, Fumoleau, Pierre, Schellens, Jan H M
Published in Investigational new drugs (01.06.2005)
Published in Investigational new drugs (01.06.2005)
Get full text
Journal Article
Phase I Trial of 6-Hour Infusion of Glufosfamide, a New Alkylating Agent With Potentially Enhanced Selectivity for Tumors That Overexpress Transmembrane Glucose Transporters: A Study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
BRIASOULIS, Evangelos, JUDSON, Ian, TZAMAKOU, Eleftheria, RAMMOU, Dimitra, WOLF, Lisa, WALKER, Ruth, HANAUSKE, Axel, PAVLIDIS, Nicholas, BEALE, Philip, WANDERS, Jantien, GROOT, Yvonne, VEERMAN, Gijbert, SCHUESSLER, Martina, NIEBCH, Georg, SIAMOPOULOS, Konstantinos
Published in Journal of clinical oncology (15.10.2000)
Published in Journal of clinical oncology (15.10.2000)
Get full text
Journal Article
Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors
Ferry A. L. M. Eskens, Gudrun A. Greim, Cornelia van Zuylen, I. Wolff, Louis J. Denis, André S. Th. Planting, Frits A. Muskiet, Jantien Wanders, Nicolas C. Barbet, Les Choi, Renaud Capdeville, Jaap Verweij, A-R. Hanauske, Uta Bruntsch
Published in Clinical cancer research (01.05.2000)
Get full text
Published in Clinical cancer research (01.05.2000)
Journal Article
New guidelines to evaluate the response to treatment in solid tumors
Therasse, Patrick, Arbuck, Susan G., Eisenhauer, Elizabeth A., Wanders, Jantien, Kaplan, Richard S., Rubinstein, Larry, Verweij, Jaap, Van Glabbeke, Martine, van Oosterom, Allan T., Christian, Michaele C., Gwyther, Steve G.
Published in Breast cancer (Tokyo, Japan) (25.10.2005)
Published in Breast cancer (Tokyo, Japan) (25.10.2005)
Get full text
Journal Article
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer
Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O'Shaughnessy, Joyce
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Get full text
Journal Article
Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
Twelves, Chris, Cortes, Javier, Vahdat, Linda T, Wanders, Jantien, Akerele, Corina, Kaufman, Peter A
Published in Clinical breast cancer (01.04.2010)
Published in Clinical breast cancer (01.04.2010)
Get full text
Journal Article
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, Patrick, Arbuck, Susan G., Eisenhauer, Elizabeth A., Wanders, Jantien, Kaplan, Richard S., Rubinstein, Larry, Verweij, Jaap, Van Glabbeke, Martine, van Oosterom, Allan T., Christian, Michaele C., Gwyther, Steve G.
Published in JNCI : Journal of the National Cancer Institute (02.02.2000)
Published in JNCI : Journal of the National Cancer Institute (02.02.2000)
Get full text
Journal Article
Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin mesylate or capecitabine: A phase III, open-label, randomized study
Cortes, Javier, Awada, Ahmad, Kaufman, Peter Andrew, Yelle, Louise, Perez, Edith A., Velikova, Galina, Wanders, Jantien, Olivo, Martin S., He, Yi, Dutcus, Corina, Simons, W. Robert, Twelves, Christopher
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase III, open-label, randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes: Subgroup analyses
Kaufman, Peter Andrew, Cortes, Javier, Awada, Ahmad, Yelle, Louise, Perez, Edith A., Wanders, Jantien, Olivo, Martin S., He, Yi, Dutcus, Corina, Twelves, Christopher
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Quality of life (QoL) and content validity in objective tumor response
Twelves, Christopher, Awada, Ahmad, Kaufman, Peter Andrew, Yelle, Louise, Perez, Edith A., Velikova, Galina, Wanders, Jantien, Olivo, Martin S., He, Yi, Dutcus, Corina, Simons, W. Robert, Cortes, Javier
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Abstract P1-12-08: Quality of Life in Patients with Locally Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes who Received Eribulin Mesylate or Capecitabine in a Phase III, Open-label, Randomized Study
Cortes, Javier, Awada, Ahmad, Twelves, Christopher, Yelle, Louise, Wanders, Jantien, Olivo, Martin S, Simons, W Robert, Dutcus, Corina E, Kaufman, Peter A
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study
Ravaud, Alain, Cerny, Thomas, Terret, Catherine, Wanders, Jantien, Bui, Binh Nguyen, Hess, Dagmar, Droz, Jean-Pierre, Fumoleau, Pierre, Twelves, Chris
Published in European journal of cancer (1990) (01.03.2005)
Published in European journal of cancer (1990) (01.03.2005)
Get full text
Journal Article
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080
Keizer, Ron J., Gupta, Anubha, Mac Gillavry, Melvin R., Jansen, Mendel, Wanders, Jantien, Beijnen, Jos H., Schellens, Jan H. M., Karlsson, Mats O., Huitema, Alwin D. R.
Published in Journal of pharmacokinetics and pharmacodynamics (01.08.2010)
Published in Journal of pharmacokinetics and pharmacodynamics (01.08.2010)
Get full text
Journal Article